Skip to content
Open access

Rational design and synthesis of sulfonamide-substituted coumarinyl-imidazolone hybrids against multidrug-resistant microbial strains: computational and biological evaluation studies.

Sep 2026 · Future Medicinal Chemistry · pp. 1-16 · 0 citations · 33 references
Medicine

TL;DR

In vitro findings identified compounds 6a, 6m, and 6n as potent leads, exhibiting significant antimicrobial activity with minimum inhibitory concentration values ranging from 15 to 500 µg/mL and antioxidant activity with DPPH IC50 values of 6.35 ± 0.51 μM, respectively.

Abstract

Aim

The longstanding use of sulfonamides has contributed to the emergence of multidrug-resistant (MDR) pathogens, posing a major challenge to antimicrobial therapy worldwide. In response, a series of sulfonamide-linked coumarinyl-imidazolone derivatives (6a-t) were rationally designed and synthesized to identify potential antimicrobial candidates.

Materials And Methods

Structures were confirmed by spectroscopic techniques. In silico studies, including molecular docking, molecular dynamics (MD) simulations, and ADMET analysis, correlated with the observed biological activity.

Results

Compounds 6a (-11.97 kcal/mol) and 6m (-9.91 kcal/mol) demonstrated excellent binding toward C. albicans sterol 14α-demethylase (CYP51) and PBP2a of methicillin-resistant S. aureus (MRSA), respectively, while MD simulations support stable complexes. In vitro findings identified compounds 6a, 6m, and 6n as potent leads, exhibiting significant antimicrobial activity with minimum inhibitory concentration (MIC) values ranging from 15 to 500 µg/mL and antioxidant activity with DPPH IC50 values of 6.05 ± 0.57, 7.57 ± 0.36, and 6.35 ± 0.51 μM, respectively. Frontier Molecular Orbital (FMO) analysis further substantiated the reactivity and stability of the lead candidates, with compound 6n displaying the lowest energy gap (2.66 eV), indicating enhanced reactivity.

Conclusions

Compounds 6a, 6m, and 6n exhibited potent antimicrobial and antioxidant activities, highlighting their promise as multifunctional antimicrobial scaffolds against MDR pathogens.

Read PDF

Similar papers

Open access Sep 2026

Triazine-Sulfonamide Hybrids: Synthesis, Antimicrobial Evaluation and In silico Investigation of their Potential Interaction with Dihydrofolate Reductase (DHFR)

Molecular dynamics simulations confirmed the dynamic stability and structural integrity of the top performing ligand DHFR complexes under simulated physiological conditions and DFT calculations provided insight into the frontier molecular orbitals and chemical reactivity descriptors, supporting the electronic stability...

Nisham Rani, Mohit Mangla, M. Sanduja et al. · 0 citations
Open access Sep 2026

Novel Azo Sulfonamide Derivatives of 5-Sulfosalicylic Acid: Synthesis, Biological Evaluation, and Computational Profiling

The escalating crisis of multi-drug-resistant pathogens necessitates the development of novel therapeutic scaffolds with enhanced membrane permeability and multi-target inhibitory potential. This study describes the design, synthesis, and mechanistic evaluation of five novel azo-sulfonamide hybrids (4a–e) derived from...

Samar H. Ali, M. El-Zahed, E. Negm et al. · 0 citations
Sep 2026

One-Pot Synthesis of Azolylmethanesulfonamido-Substituted Oxadiazoles, Thiadiazoles, and Triazoles as Antimicrobial, Antioxidant, and Anticancer Agents Supported by Molecular Docking Studies

A novel series of azolylmethanesulfonamido-substituted oxadiazoles, thiadiazoles, and triazoles synthesized via an efficient one-pot protocol facilitated by TMSNCS demonstrated a broad spectrum of biological profiles, with multiple derivatives exhibiting potent antibacterial, antifungal, antioxidant, and anticancer pro...

M. Kalyani, S. Sireesha, G. D. Reddy et al. · 0 citations
Aug 2026

Molecular hybridization strategy for the design of benzimidazolyl-retrochalcone derivatives as antifungal agents: Synthesis, characterization, and CYP51-based computational evaluation

Abstract The growing resistance of Candida species highlights the need for antifungal agents targeting validated fungal enzymes. In this study, a series of benzimidazole-based retrochalcone derivatives was designed, and evaluated as potential inhibitors of lanosterol 14α-demethylase (CYP51). The design strategy combine...

Koné Aboudramane, Souleymane Coulibaly, Nanan Landry Frejus et al. · 0 citations
Open access Sep 2026

Schiff Base Derivatives of Benzothiazole and Benzamide as Promising Antimicrobial Agents: Integrated In Silico and In Vitro Evaluation.

A library of Schiff-base derivatives of benzothiazoles (2a-2f) and benzamides (5a-5i) was designed, synthesised via a microwave-assisted approach, and comprehensively characterised by 1H-/13C-NMR, FT-IR, and UV-Vis spectroscopy, predicting favourable pharmacokinetics and low toxicity.

T. Ogunnupebi, G. Oduselu, O. F. Elebiju et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.